In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC).
about
Linking form to function: Biophysical aspects of artificial antigen presenting cell designNanoengineering approaches to the design of artificial antigen-presenting cellsDynamic regulation of functionally distinct virus-specific T cells.Nanoscale artificial antigen presenting cells for T cell immunotherapyTowards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors.CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting CellsModulation of MHC binding by lateral association of TCR and coreceptor.Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy.Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cellsAntigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells.Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity.Artificial antigen-presenting cells for use in adoptive immunotherapy.Dimeric MHC-peptides inserted into an immunoglobulin scaffold as new immunotherapeutic agents.Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model.Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma.The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer ImmunotherapiesEx vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.The right touch: design of artificial antigen-presenting cells to stimulate the immune system
P2860
Q27002652-A99A1174-2EED-4EA8-8643-7E7646CE13FFQ27023634-98948167-DFD1-492F-B6E9-ACA655BE294BQ33734502-68E62BAB-8F32-46D3-9933-CCE36937F1E8Q33968408-B35F84D3-7C5D-4D6B-9AF0-2454712734C3Q34428078-47436DA6-6F9D-4018-8FA1-1C58B6FBEAC1Q35230365-EA4B04F5-B2DB-48FF-B36E-74414FF1D504Q35563107-E64A6D56-DA57-4A8F-82D4-E1DBE2E643ECQ36379215-E48B8DDF-2591-44AC-8FC0-C9F27EE3CFF0Q37370230-FF313747-3776-437F-84E2-CD1ECCFE3A3BQ37515801-2D38AC0A-9E8C-4316-BB61-056899A026DFQ37708824-56740D39-4FFE-4C38-BE7D-992E789B6CEEQ37731672-57C45688-7124-4535-B9A0-7BCEA9EF9590Q37778699-2D7936AC-C276-48C2-AE8B-9ABB2718FDA0Q37857379-00F15671-39EB-4D6B-B373-BB10234C4291Q38684217-B300E790-3898-4CC5-A08C-4E05B942A69FQ39111861-473DF71A-CD60-4AA7-9EB0-1A27A31CC84EQ41442041-2BBFF029-7D88-4DBF-ABF3-3CDC80BE6234Q42752862-AA21F9CD-8A4E-40B2-8273-B27F4D78CA18Q58619853-B43F45AC-185B-417B-9072-56F67C2B1FB9
P2860
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo functional efficacy of ...... tigen presenting cells (aAPC).
@en
In vivo functional efficacy of ...... icial antigen presenting cells
@nl
type
label
In vivo functional efficacy of ...... tigen presenting cells (aAPC).
@en
In vivo functional efficacy of ...... icial antigen presenting cells
@nl
prefLabel
In vivo functional efficacy of ...... tigen presenting cells (aAPC).
@en
In vivo functional efficacy of ...... icial antigen presenting cells
@nl
P2093
P2860
P1476
In vivo functional efficacy of ...... tigen presenting cells (aAPC).
@en
P2093
Andreas Mackensen
Christine Krueger
Jonathan P Schneck
Malarvizhi Durai
Mathias Oelke
Zhaohui Ye
P2860
P2888
P304
P356
10.1007/S00262-008-0542-1
P577
2008-06-18T00:00:00Z